AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
The tenure of contract will be upto 10 years from date of signing the contract/installation.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Better serving global partners and advancing healthcare innovation
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Subscribe To Our Newsletter & Stay Updated